Fig. 1.

Up-regulations of lysyl oxidase-like protein (LOXS) genes in both anterior cruciate ligament (ACL) and medial collateral ligament (MCL) after (TGF-β1) treatments with different concentrations by Reversed Transcript PCR. Through (GAPDH) (transforming growth factor-β1 glyceraldehyde phosphate dehydrogenase), the PCR arrays showed higher expressions of LOXs in MCL than these in ACL after treated with TGF-β1 (chose the concentrations of 1 ng, 5 ng, 50 ng). Size (in bp) of PCR products are indicated to the left of each pane